カテゴリー： Transparency Market Research, 世界, 医療/バイオ

慢性完全閉塞装置の世界市場2023～2031：製品別

◆英語タイトル：Chronic Total Occlusion Devices Market (Product Type: Microcatheters, Guidewires, Crossing Devices, Re-entry Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23MA105）◆商品コード：TMR23MA105
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年3月3日
◆ページ数：145
◆レポート形式：英語 / PDF
◆納品方法：Eメール（納期はお問い合わせください。）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の本市場調査報告書によると、世界の慢性完全閉塞用デバイス市場規模が、2023年の17億ドルから2031年には29億ドルまでCAGR 6.1%成長すると予測されています。本書は慢性完全閉塞用デバイスの世界市場について多角的に調査・分析し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、製品別（マイクロカテーテル、ガイドワイヤー、閉塞デバイス、リエントリーデバイス、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、主要ポイントなどの内容を掲載しています。なお、本書には、Medtronic、Boston Scientific Corporation、Acrostak Int. Distr. Sàrl、Abbott、Asahi Intecc Co., Ltd.、Cardinal Health、Cook Medical、Merit Medical Systems、MicroPort Scientific Corporation、Penumbra, Inc.、Koninklijke Philips N.V.、Terumo India Private Limitedなどの企業情報が含まれています。
・序論
・仮定
・調査方法
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症分析
・世界の慢性完全閉塞用デバイス市場規模：製品別
- マイクロカテーテルの市場規模
- ガイドワイヤーの市場規模
- 閉塞デバイスの市場規模
- リエントリーデバイスの市場規模
- その他製品別の市場規模
・世界の慢性完全閉塞用デバイス市場規模：エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の慢性完全閉塞用デバイス市場規模：地域別
- 北米の慢性完全閉塞用デバイス市場規模
- ヨーロッパの慢性完全閉塞用デバイス市場規模
- アジア太平洋の慢性完全閉塞用デバイス市場規模
- 中南米の慢性完全閉塞用デバイス市場規模
- 中東・アフリカの慢性完全閉塞用デバイス市場規模
・競争状況
・企業情報
・主要ポイント

Chronic Total Occlusion Devices Market – Scope of Report
TMR’s report on the global chronic total occlusion devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global chronic total occlusion devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronic total occlusion devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the chronic total occlusion devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global chronic total occlusion devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global chronic total occlusion devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global chronic total occlusion devices market.

The report delves into the competitive landscape of the global chronic total occlusion devices market. Key players operating in the global chronic total occlusion devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global chronic total occlusion devices market profiled in this report.

Key Questions Answered in Global Chronic Total Occlusion Devices Market Report
• What is the sales/revenue generated by chronic total occlusion devices across all regions during the forecast period?
• What are the opportunities in the global chronic total occlusion devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Chronic Total Occlusion Devices Market – Research Objectives and Research Approach
The comprehensive report on the global chronic total occlusion devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global chronic total occlusion devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global chronic total occlusion devices market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Total Occlusion Devices Market
4. Market Overview
    4.1. Introduction
        4.1.1. Definition
        4.1.2. Industry Evolution /Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Disease Prevalence & Incidence Rate globally with key countries
    5.2. Technological Advancements
    5.3. Regulatory Scenario by Region/globally
    5.4. COVID-19 Pandemic Impact on Industry
6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Microcatheters
        6.3.2. Guidewires
        6.3.3. Crossing Devices
        6.3.4. Re-entry Devices
        6.3.5. Others
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by End-user, 2017–2031
        7.3.1. Hospitals
        7.3.2. Ambulatory Surgical Centers
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by End-user
8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region
    8.1. Key Findings
    8.2. Market Value Forecast, by Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Total Occlusion Devices Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by Product Type, 2017–2031
        9.2.1. Microcatheters
        9.2.2. Guidewires
        9.2.3. Crossing Devices
        9.2.4. Re-entry Devices
        9.2.5. Others
    9.3. Market Value Forecast, by End-user, 2017–2031
        9.3.1. Hospitals
        9.3.2. Ambulatory Surgical Centers
        9.3.3. Others
    9.4. Market Value Forecast, by Country, 2017–2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product Type
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Microcatheters
        10.2.2. Guidewires
        10.2.3. Crossing Devices
        10.2.4. Re-entry Devices
        10.2.5. Others
    10.3. Market Value Forecast, by End-user, 2017–2031
        10.3.1. Hospitals
        10.3.2. Ambulatory Surgical Centers
        10.3.3. Others
    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product Type
        10.5.2. By End-user
        10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Microcatheters
        11.2.2. Guidewires
        11.2.3. Crossing Devices
        11.2.4. Re-entry Devices
        11.2.5. Others
    11.3. Market Value Forecast, by End-user, 2017–2031
        11.3.1. Hospitals
        11.3.2. Ambulatory Surgical Centers
        11.3.3. Others
    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product Type
        11.5.2. By End-user
        11.5.3. By Country/Sub-region
12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Microcatheters
        12.2.2. Guidewires
        12.2.3. Crossing Devices
        12.2.4. Re-entry Devices
        12.2.5. Others
    12.3. Market Value Forecast, by End-user, 2017–2031
        12.3.1. Hospitals
        12.3.2. Ambulatory Surgical Centers
        12.3.3. Others
    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product Type
        12.5.2. By End-user
        12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Microcatheters
        13.2.2. Guidewires
        13.2.3. Crossing Devices
        13.2.4. Re-entry Devices
        13.2.5. Others
    13.3. Market Value Forecast, by End-user, 2017–2031
        13.3.1. Hospitals
        13.3.2. Ambulatory Surgical Centers
        13.3.3. Others
    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product Type
        13.5.2. By End-user
        13.5.3. By Country/Sub-region
14. Competition Landscape
    14.1. Market Player – Competition Matrix (by tier and size of companies)
    14.2. Market Share Analysis, by Company, 2022
    14.3. Company Profiles
        14.3.1. Medtronic
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Product Type Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Boston Scientific Corporation
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Product Type Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Acrostak Int. Distr. Sàrl
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Product Type Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Abbott
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Product Type Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. Asahi Intecc Co., Ltd.
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Product Type Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Cardinal Health
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Product Type Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Cook Medical
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Product Type Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Merit Medical Systems
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Product Type Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
            14.3.8.5. Strategic Overview
        14.3.9. MicroPort Scientific Corporation
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Product Type Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
            14.3.9.5. Strategic Overview
        14.3.10. Penumbra, Inc.
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Product Type Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview
        14.3.11. Koninklijke Philips N.V.
            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.11.2. Product Type Portfolio
            14.3.11.3. Financial Overview
            14.3.11.4. SWOT Analysis
            14.3.11.5. Strategic Overview
        14.3.12. Terumo India Private Limited
            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.12.2. Product Type Portfolio
            14.3.12.3. Financial Overview
            14.3.12.4. SWOT Analysis
            14.3.12.5. Strategic Overview
        14.3.13. Teleflex Incorporated
            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.13.2. Product Type Portfolio
            14.3.13.3. Financial Overview
            14.3.13.4. SWOT Analysis
            14.3.13.5. Strategic Overview
        14.3.14. Becton, Dickinson and Company
            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.14.2. Product Type Portfolio
            14.3.14.3. Financial Overview
            14.3.14.4. SWOT Analysis
            14.3.14.5. Strategic Overview
        14.3.15. Reflow Medical
            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.15.2. Product Type Portfolio
            14.3.15.3. Financial Overview
            14.3.15.4. SWOT Analysis
            14.3.15.5. Strategic Overview
        14.3.16. Nitiloop
            14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.16.2. Product Type Portfolio
            14.3.16.3. Financial Overview
            14.3.16.4. SWOT Analysis
            14.3.16.5. Strategic Overview

List of Tables

Table 01: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 02: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 05: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: North America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 07: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 08: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Europe Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 11: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: Asia Pacific Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 14: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Latin America Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

Table 17: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Middle East & Africa Chronic Total Occlusion Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 慢性完全閉塞装置の世界市場2023～2031：製品別(Chronic Total Occlusion Devices Market (Product Type: Microcatheters, Guidewires, Crossing Devices, Re-entry Devices, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 排痰補助デバイスの世界市場（2022～2031）：製品別、エンドユーザー別
  • BiPAPデバイスの世界市場（2022～2031）：疾患別、年齢層別
  • デジタル創傷測定装置の世界市場2023～2031：製品別、創傷別、技術別
  • 自己採血&保管装置のアジア太平洋市場2023～2031：製品別、用途別

    • ◆H&Iグローバルリサーチのお客様（例）◆